RINVOQ tablets 30mg (Upadacitinib hydrate), manufactured by AbbVie (YJ code: 3999048G3020, standard: 30mg 1 tablet), is a Janus kinase (JAK) inhibitor. It is indicated for the treatment of various inflammatory conditions in adults and some pediatric patients, including moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn’s disease.
RINVOQ tablets 30mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
